| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6249354 | Transplantation Proceedings | 2011 | 9 Pages |
Abstract
The impact of SRL and ERL on laboratory values and rejection rates, as well as on clinical parameters, is similar with a slight advantage to ERL regarding lipids and rate of infections (not significant). Both SRL and ERL allow an important reduction of calcineurin-therapy; however, both drugs have considerable side effects, which often require discontinuation of therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
B. Baur, M. Oroszlan, O. Hess, T. Carrel, P. Mohacsi,